Skip to main content

Cookies

This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to the Privacy Policy and Terms of Use. Please read our cookie policy for more information on the use of cookies on this website.

Top
  • COVID-19
    • COVID-19 Resources
  • Solutions
    • By Market
      • Academic Research
      • Agriculture
      • Biobanking
      • Government
      • Pharma and Biotech
      • Research Foundations
    • By Application
      • Clinical Trial Sample Management
      • Discovery, Compound Management and Biologics
      • Molecular Diagnostic Solutions
      • Regenerative Medicine and Cell Therapy
      • Sample Preparation and Lab Services
      • Sample Transport and Cold-Chain Logistics
      • Vaccine Development
    • Geography
      • Asia-Pacific
      • Europe
      • North America
  • Products
    • Azenta Life Sciences Virtual Booth
    • Automated Sample Storage Systems
      • Cold Storage (Ambient to -20°C)
      • Ultra Cold Storage (ULT -80°C)
      • Cryogenic Storage (-190°C)
    • Consumables & Instruments
      • Sample Tube Solutions
      • PCR & Microplate Solutions
      • Sample Cooling & Heating Labware
    • Informatics Platforms & LIMS/LIS
    • Integrations
    • Sterilization Services
    • Microplate Coding Services
  • Services
    • Genomics Services by GENEWIZ
    • Sample and Material Management Solutions
    • Sample and Material Storage
    • Clinical Trial Management
    • Drug Products Storage and Distribution
    • Sample Sourcing
    • Sample Prep and Lab Services
    • Lab Moving and Biological Transport
    • Business Continuity and Risk Mitigation
  • Support
    • Technical Support
    • Product Support Plans
    • Product Updates
    • Sample Tube Pack Request
    • Plate & Seal Sample Request
  • Resources
  • Blog
  • About Us
    • Events
    • About Azenta Life Sciences
    • Management Team
    • Board of Directors
    • Global Locations
    • Investor Relations
    • News
    • Careers
    • Quality
    • Certifications
  • Contact Us

Utility Navigation

  • Life Sciences Customer Login
  • GENEWIZ
  • BioInventory Login
  • Portals Login
  • Portals
  • Careers
Home

Utility Navigation

  • Life Sciences Customer Login
  • GENEWIZ
  • BioInventory Login
  • Portals Login
  • Portals
  • Careers

Main Navigation

  • COVID-19
    Vaccine Development
    Vaccine Development

    Accelerating global operations to manage and process samples critical to vaccine development.

    Azenta Life Sciences Virtual Booth
    Azenta Life Sciences Virtual Booth

    The exhibition experience to your desktop or mobile device

    • COVID-19 Resources
  • Solutions
    • By Market
      • Academic Research
      • Agriculture
      • Biobanking
      • Government
      • Pharma and Biotech
      • Research Foundations
    • By Application
      • Clinical Trial Sample Management
      • Discovery, Compound Management and Biologics
      • Molecular Diagnostic Solutions
      • Regenerative Medicine and Cell Therapy
      • Sample Preparation and Lab Services
      • Sample Transport and Cold-Chain Logistics
      • Vaccine Development
    • Geography
      • Asia-Pacific
      • Europe
      • North America
    Resources Center

    Learn about sample management best practices, gain advice from industry leaders, gain access to global regulatory and logistics guidelines and find simple support tools that can help you make better sample management decisions.

    Resources Center
  • Products
    Azenta Sample Pack and Catalog
    Sample Tube Pack Request

    Improve sample tracking, ensure sample integrity and drive process efficiency with Azenta Sample Storage Tubes. Explore the range, and select the best tube for your workflow.

    Low DNA Binding Microplates
    Low Binding Microplates

    Ultra low DNA binding microplates made from PP, fit for Next Generation Sequencing (NGS) and other sensitive applications with ultra-low DNA input. Off the shelf options. Custom solutions on request.

    • Azenta Life Sciences Virtual Booth
    • Automated Sample Storage Systems
      • Cold Storage (Ambient to -20°C)
      • Ultra Cold Storage (ULT -80°C)
      • Cryogenic Storage (-190°C)
    • Consumables & Instruments
      • Sample Tube Solutions
      • PCR & Microplate Solutions
      • Sample Cooling & Heating Labware
    • Informatics Platforms & LIMS/LIS
    • Integrations
    • Sterilization Services
    • Microplate Coding Services
  • Services
    Clinical Trial Management
    Clinical Trial Management

    Life science organizations must collect and manage large numbers of research samples to bring a new therapeutic or diagnostic to market. This is a complex process.

    Sample Preparation & Lab Analytical Services
    Genomics Services by GENEWIZ

    Comprehensive genomics services provide end to end solutions and best-in-class data quality from the trusted experts in genomics.

    • Genomics Services by GENEWIZ
    • Sample and Material Management Solutions
    • Sample and Material Storage
    • Clinical Trial Management
    • Drug Products Storage and Distribution
    • Sample Sourcing
    • Sample Prep and Lab Services
    • Lab Moving and Biological Transport
    • Business Continuity and Risk Mitigation
  • Support
    disaster recovery
    How Safe Are Your Samples?

    Plastic storage tubes are used in laboratories worldwide to store biological and chemical samples.

    Product Support Plans
    Product Support Plans

    Azenta  Life Sciences' world class service team is committed to ensuring you meet your business objectives by providing a flexible portfolio of service products designed to optimize up-time and productivity.

    • Technical Support
    • Product Support Plans
    • Product Updates
    • Sample Tube Pack Request
    • Plate & Seal Sample Request
  • Resources
  • Blog
  • About Us
    Putting a Sample Kit in an envelope
    Quality Assurance Certifications

    Azenta Life Sciences has established, documented, implemented and currently maintains a quality management system that fulfills the needs of customers.

    About Azenta Life Sciences
    About Azenta Life Sciences

    We are Azenta Life Sciences. We provide unrivaled sample exploration and management solutions to help our customers accelerate discovery, development and delivery.

    • Events
    • About Azenta Life Sciences
    • Management Team
    • Board of Directors
    • Global Locations
    • Investor Relations
    • News
    • Careers
    • Quality
    • Certifications
  • Contact Us

Blog

You are here

  • Home
  • Blog
  • Singapore Confirms Commitment to Genetics and Genomics with Two Big Launches

Singapore Confirms Commitment to Genetics and Genomics with Two Big Launches

January 2, 2020

DNA molecule

 

Singapore is poised for prominence in genetics and genomics – and the move toward personalized medicine.

Researchers at the Genome Institute of Singapore recently created the world’s largest genetic data bank of Asian populations. The country also launched a new center for genomic medicine with the SingHealth Duke-NUS Genomic Medicine Centre.

Individually, each of these achievements will bring about big things for genomic research and medicine. But together, they can propel patient care into another realm and substantiate the shift to precision medicine.

 

Genome Institute of Singapore (GIS)

The Chan Zuckerberg Initiative (CZI), established by Facebook founder Mark Zuckerberg and his wife Priscilla Chan, recently presented a grant to the Genome Institute of Singapore (under the Human Cell Atlas program) to fund genome mapping of Asian subpopulations.

The endowment from CZI will prove instrumental as scientists and doctors work to better diagnose rare diseases and find the causes of chronic illnesses based on whole-genome sequencing of some 5K Singaporeans.

This timing of this database couldn’t be better given the lack of Asian genetic information in databases around the world.

The team at GIS was able to identify 98.3 million genetic variants across Singaporean genomes. More than half of these had not been previously represented. This is crucial, because data about a patient’s genome can facilitate precision medicine.

Professor Patrick Tan, executive director at GIS, explains.

"To be able to identify who's at most risk of developing chronic disease and who will best respond to a particular therapy, we can allocate the right drugs to the right patients at the right time."

Professor Liu Jianjun, deputy executive director and senior group leader of human genetics at GIS, says the database is a milestone for Singapore and all countries in Asia.

"Now, we have a map. Different groups can pick up the map and study it in more detail, read and interpret it."

 

SingHealth Duke-NUS Genomic Medicine Centre (SDGMC)

Genetic abnormalities and mutations are often inherited and can be the cause of diseases such as cancer and heart disease. So, it’s vital to recognize and react to the genetic elements of each person to diagnose specific diseases and develop “customized” treatment for it. This is the essence of precision medicine.

With the opening of SDGMC, doctors can provide specialized genetics care and facilitate genomics research and education across SingHealth institutes to expand care for patients and families with genetic diseases.

Additionally, SDGMC will initiate genetics clinics in SingHealth hospitals and institutions where patients and family members with genetic disorders or genetically-linked conditions can go through risk assessment, genetic testing, and genetic counseling.

These specialty genetics clinics will alleviate the need for patients to get a referral to a separate site for genetics services, which improves communication between clinical and genetics teams and enhances precision care and support for patients and family members.

Professor Ivy Ng, Group CEO, SingHealth shares, “The SingHealth Duke-NUS Genomic Medicine Centre will seamlessly integrate genomics care into our healthcare institutions, providing crucial genomics perspectives and timely intervention across medical specialties. This will allow for more accurate diagnosis and personalized treatment for patients with genetic diseases, and more effective risk assessment, monitoring and intervention for their family members who are at risk.”

Beyond better patient care, the SDGMC will establish a registry of genetic disorders to help physicians and researchers recognize disease trends, develop treatment plans, and follow patient outcomes to better manage genetic disorders. The Centre will also work with faculty at Duke-NUS Medical School to research new biomarkers and genetic disorders for improved diagnosis and treatment.

As precision medicine grows, Azenta Life Sciences supports scientists and physicians like those at GIS and SDGMC with world-class sample management and global genomics services.

 

  • Genomics
  • Sample Management
  • Sample Storage
  • Biobanking
Home
Facebook twitter youtube linkedin
Copyright © 2023 Azenta US, Inc.

Footer menu

  • Privacy Policy
  • Cookie Policy
  • Terms and Conditions
  • Terms of Use
  • Careers
  • Subscribe